CLEC14A
C-type lectin domain family 14 member A
Also known as: C14orf27, CLC14_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86T13
- Gene
- CLEC14A
- Ensembl
- ENSG00000176435
- Chromosome
- 14
- Canonical length
- 490 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. This family member plays a role in cell-cell adhesion and angiogenesis. It functions in filopodia formation, cell migration and tube formation. Due to its presence at higher levels in tumor endothelium than in normal tissue endothelium, it is considered to be a candidate for tumor vascular targeting. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
490 residues, UniProt reviewed canonical sequence.
>Q86T13|CLEC14A
1 MRPAFALCLL WQALWPGPGG GEHPTADRAG CSASGACYSL HHATMKRQAA EEACILRGGA
61 LSTVRAGAEL RAVLALLRAG PGPGGGSKDL LFWVALERRR SHCTLENEPL RGFSWLSSDP
121 GGLESDTLQW VEEPQRSCTA RRCAVLQATG GVEPAGWKEM RCHLRANGYL CKYQFEVLCP
181 APRPGAASNL SYRAPFQLHS AALDFSPPGT EVSALCRGQL PISVTCIADE IGARWDKLSG
241 DVLCPCPGRY LRAGKCAELP NCLDDLGGFA CECATGFELG KDGRSCVTSG EGQPTLGGTG
301 VPTRRPPATA TSPVPQRTWP IRVDEKLGET PLVPEQDNSV TSIPEIPRWG SQSTMSTLQM
361 SLQAESKATI TPSGSVISKF NSTTSSATPQ AFDSSSAVVF IFVSTAVVVL VILTMTVLGL
421 VKLCFHESPS SQPRKESMGP PGLESDPEPA ALGSSSAHCT NNGVKVGDCD LRDRAEGALL
481 AESPLGSSDALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLEC14A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 70 nTPM
- adipose tissue: 70 nTPM
- lung: 57 nTPM
- breast: 54 nTPM
- tongue: 41 nTPM
- endometrium: 34 nTPM
Single-cell type
- vascular endothelial cells: 329 nCPM
- lymphatic endothelial cells: 62 nCPM
- hepatic stellate cells: 26 nCPM
- oligodendrocyte progenitor cells: 11 nCPM
- fibro-adipogenic progenitors: 9.3 nCPM
- pericytes: 8.7 nCPM
Immune cell
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 19 nTPM
- white matter: 18 nTPM
- medulla oblongata: 18 nTPM
- thalamus: 18 nTPM
- cerebellum: 15 nTPM
- midbrain: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.13
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell migration
- cell migration involved in sprouting angiogenesis
- lymphangiogenesis
- vascular endothelial growth factor receptor-2 signaling pathway
- vascular endothelial growth factor receptor-3 signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLEC14A as an antibody target. Whether an autoantibody or antibody against CLEC14A could matter depends on whether native CLEC14A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLEC14A is annotated at the cell surface, where native CLEC14A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLEC14A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...